Adjuvant radiotherapy improves progression-free survival in intracranial atypical meningioma

BACKGROUND: Meningiomas are the most common primary tumors of the central nervous system. In patients with WHO grade I meningiomas no adjuvant therapy is recommended after resection. In case of anaplastic meningiomas (WHO grade III), adjuvant fractionated radiotherapy is generally recommended, regar...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Oncol
Main Authors: Hemmati, Saman Moritz, Ghadjar, Pirus, Grün, Arne, Badakhshi, Harun, Zschaeck, Sebastian, Senger, Carolin, Acker, Güliz, Misch, Martin, Budach, Volker, Kaul, David
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6719347/
https://ncbi.nlm.nih.gov/pubmed/31477146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-019-1368-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados